The US Department of Justice (DOJ) has formally moved to reclassify cannabis as a less harmful Schedule III drug in a move that could have a significant economic impact on the cannabis industry. The Attorney General has submitted a notice of proposed rulemaking which – if given final approval by Drug Enforcement Agency (DEA) – […]
Search
Subscribe for News and Updates
Footer
Search
Management Consulting
- Debt and Equity Capital Intellectual Property Valuation
- Intellectual Property Department Operations
- Intellectual Property Strategy & Analytics
- Risk Management
- Royalty & License Compliance
- Trade Secret Management
- Valuation – Bankruptcy
- Valuation – Business Enterprise
- Valuation – Intellectual Property
- Valuation – Intellectual Property Transaction
- Valuation – Litigation Dispute
- Valuation – Merger & Acquisition
- Valuation – Patent
- Venture Development & Innovation Management
Advisory
- Intellectual Property Acquisitions
- Intellectual Property Auctions
- Ocean Tomo Bid-Ask Market®
- Corporate Restructuring
- Corporate M&A
- Investment Research
- Investment Banking
- Patent Indexes
- Patent Monetization Strategy
- Private Equity
- Private Sales
- Royalty Securitizations
- Intellectual Property Transactions